| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.8 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |